文献速递耳科与耳神经小儿耳鼻咽喉

基因检测对听力干预的影响

Impact of Genetic Testing on Hearing Interventions.
PubMed 文献 · Laryngoscope · 2022-09-27

研究纳入111例0-18岁感音神经性听力损失(SNHL)且为助听器或人工耳蜗候选但未使用的儿童,在干预前接受听力损失基因panel检测。多因素logistic回归显示,发现遗传学诊断者后续接受干预的可能性为无诊断者的4.6倍(p=0.035),双侧听力损失和较早接受基因检测也与干预可能性增加相关。

要点

  • 遗传学诊断与SNHL儿童后续使用助听器或人工耳蜗的可能性增加相关(OR约4.6,p=0.035)。
  • 双侧听力损失和较早接受基因检测与干预可能性增加相关。
  • 研究为临床指南推荐基因检测提供了治疗决策方面的额外支持。

核心结论

  • 被诊断为遗传学诊断的SNHL儿童后续使用助听器或人工耳蜗的可能性显著更高。
  • 该结果为临床指南推荐基因检测提供了额外支持,不仅因预后判断的影响,也因对治疗决策的影响。

研究设计与样本

  • 研究纳入0-18岁感音神经性听力损失(SNHL)儿童,这些儿童为助听器或人工耳蜗候选但未使用,并在开始干预前接受了听力损失基因panel检测。
  • 在385例接受听力损失基因panel检测的SNHL儿童中,111例被纳入分析。
  • 采用单因素分析识别助听器验配或人工耳蜗植入的预测因素,多因素logistic回归评估人口学和临床因素对后续干预的影响。

主要发现

  • 纳入儿童的中位年龄为7.5岁。
  • 56%的儿童属于代表性不足的少数族裔,71%为非白人,71%为公共保险。
  • 发现遗传学诊断的儿童后续接受干预的可能性为无遗传学诊断者的4.6倍(p=0.035)。
  • 双侧听力损失和较早接受基因检测与干预可能性增加相关。

临床怎么用

  • 原文未据此给出推荐。
  • 作者认为,该研究为临床指南推荐基因检测提供了额外支持,不仅因预后判断的影响,也因对治疗决策的影响。

局限性

  • 原文未报告局限性。

以上解读依据论文摘要(全文未开放获取或许可不允许翻译转载)。

原文

OBJECTIVE: Clinical guidelines recommend genetic testing when evaluating congenital and late-onset sensorineural hearing loss (SNHL). Genetic diagnoses can provide parents additional information regarding anticipated hearing loss progression, comorbid conditions, and family planning. Additionally, obtaining a genetic diagnosis may increase parental acceptance of hearing loss and subsequent pursuit of intervention. This study evaluates the association between genetic diagnoses and hearing loss intervention. METHODS: We included children ages 0-18 years with SNHL who were hearing aid or cochlear implant candidates but non-users and underwent hearing-loss gene panel testing prior to initiating intervention. Univariate analyses were performed to identify predictors of hearing aid fitting or cochlear implantation. Multivariate logistic regression evaluated the impact of demographic and clinical factors on subsequent intervention. RESULTS: Of the 385 children with SNHL who underwent hearing loss gene panel testing, 111 were included. Median age was 7.5 years. 56% were underrepresented minorities, 71% were non-White, and 71% were publicly insured. Those found to have a genetic diagnosis were 4.6 times as likely to subsequently undergo intervention (p = 0.035). Additionally, bilateral hearing loss and earlier age of genetic testing were associated with increased likelihood of intervention. CONCLUSION: Up to half of children with SNHL are suspected to have an underlying genetic etiology. Children diagnosed with a genetic diagnosis are significantly more likely to subsequently utilize hearing aids or cochlear implantation. This provides additional support for clinical guidelines recommending genetic testing not only due to the impact of prognostication but also on treatment decision-making. LEVEL OF EVIDENCE: 4 Laryngoscope, 133:1982-1986, 2023.

来源:Laryngoscope,查看原文。版权归原作者所有。

引用

  1. Brodie KD, Liao EN, Florentine MM, et al. Impact of Genetic Testing on Hearing Interventions. Laryngoscope. 2022. PMID: 36165585. doi:10.1002/lary.30409

供执业医师工作参考,不替代临床判断;数值与分级以指南原文为准。